What it's for (Indications)
- Proparacaine hydrochloride ophthalmic solution is primarily indicated for topical anesthesia in ophthalmology.
- Its rapid onset and short duration of action make it suitable for a variety of diagnostic and minor surgical procedures involving the eye.
- Specific indications include, but are not limited to, tonometry (measurement of intraocular pressure), gonioscopy (examination of the anterior chamber angle), removal of foreign bodies from the cornea or conjunctiva, and removal of sutures.
- It is also utilized as a preparatory anesthetic agent prior to other minor ocular procedures, such as scraping for diagnostic purposes or for patients experiencing severe ocular pain requiring temporary relief during examination.
- The anesthetic effect helps to minimize discomfort and facilitate patient cooperation during these interventions, ensuring a more effective and less traumatic experience for the patient.
- This drug provides superficial anesthesia to the cornea and conjunctiva, aiding in patient comfort for brief interventions.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For topical ophthalmic anesthesia, proparacaine hydrochloride 0.5% ophthalmic solution is typically administered as follows: For procedures requiring light anesthesia, such as tonometry or gonioscopy, one to two drops are instilled into the conjunctival sac immediately before the procedure. For more extensive or prolonged procedures, such as the removal of foreign bodies or sutures, one to two drops may be instilled every 5 to 10 minutes for 5 to 7 doses, as needed, to maintain adequate anesthesia. It is crucial to adhere strictly to the recommended dosage and frequency to mitigate the risk of corneal damage, including epithelial opacification, perforation, and ulceration, which can result from excessive or prolonged use. Patients must be clearly instructed against self-administration beyond the immediate procedural necessity, as continuous use can have severe adverse effects on corneal health. Prescribing clinicians should evaluate individual patient needs and procedural requirements to determine the most appropriate dosing regimen and duration of use. |
Safety & Warnings
Common Side Effects
- The most commonly reported side effects following the ophthalmic administration of proparacaine hydrochloride are transient in nature and typically occur immediately after instillation.
- These include mild stinging, burning, or itching sensations in the eye, along with conjunctival redness, tearing, and a temporary sensation of foreign body presence.
- Photophobia may also occur temporarily.
- Less commonly, but of greater clinical concern, are potential ocular toxicities associated with prolonged or excessive use.
- These can manifest as punctate keratitis, epithelial desquamation, corneal edema, and in severe cases, irreversible corneal opacification, ulceration, and even perforation, particularly when the drug is abused or used continuously by patients.
- Allergic reactions, though rare, can range from contact dermatitis of the eyelids to severe systemic anaphylactic responses.
- Other rare systemic effects, typically seen with higher systemic absorption, include central nervous system excitation or depression, and cardiovascular effects, but these are exceedingly uncommon with appropriate topical ophthalmic use.
- Patients should be advised to report any persistent or worsening symptoms immediately to their healthcare provider.
Serious Warnings
- Black Box Warning: Proparacaine hydrochloride does not carry a specific Black Box Warning from the U.S. Food and Drug Administration (FDA). However, healthcare professionals and patients must be made aware of several serious safety concerns associated with its use, particularly the potential for severe ocular toxicity upon prolonged or repeated administration. **Serious Warning: Corneal Toxicity with Prolonged Use:** While invaluable for short-term diagnostic and procedural anesthesia, continuous or abusive use of topical ophthalmic anesthetics like proparacaine can lead to significant and potentially irreversible corneal damage. This includes, but is not limited to, epithelial punctate keratitis, diffuse epithelial desquamation, stromal edema, corneal opacification, and ultimately, corneal ulceration and perforation. These adverse effects can severely compromise vision and necessitate surgical intervention. Therefore, proparacaine is strictly intended for professional use during single procedures and should never be prescribed for prolonged self-administration or for the management of chronic ocular pain, as this practice can lead to profound and vision-threatening complications. Patients must be explicitly counseled on these risks and instructed against any unauthorized or extended use, understanding that the benefits are limited to acute procedural needs.
- Proparacaine hydrochloride ophthalmic solution is strictly for topical ophthalmic use and must not be injected.
- A paramount warning concerns the potential for severe corneal damage, including permanent opacification, ulceration, and perforation, especially with prolonged or repeated self-administration.
- Patients must be explicitly instructed to avoid continuous use and to seek immediate medical attention for any persistent ocular pain or discomfort rather than self-treating with this anesthetic.
- Due to the temporary loss of sensation, the anesthetized eye is highly susceptible to accidental injury from rubbing, foreign bodies, or exposure to irritants; therefore, patients should be advised to protect their eyes until normal sensation returns.
- Caution is advised in individuals with known hypersensitivity to ester-type local anesthetics or any component of the formulation, as allergic reactions, though rare, can be severe.
- Although systemic absorption is typically minimal, clinicians should exercise caution in patients with cardiac disease, hyperthyroidism, or systemic allergies, given the theoretical risk of systemic effects.
- The use of topical anesthetics can also mask serious ocular conditions, delaying diagnosis and appropriate treatment.
- Furthermore, anesthetized eyes may be more vulnerable to infection; hence, sterile technique during administration is crucial.
How it Works (Mechanism of Action)
Proparacaine hydrochloride exerts its local anesthetic effect by stabilizing the neuronal membrane, thereby preventing the initiation and transmission of nerve impulses. As an ester-type local anesthetic, its primary mechanism involves the reversible blockage of voltage-gated sodium channels within the nerve cell membranes. This inhibition prevents the rapid influx of sodium ions into the neuron, which is a critical step for depolarization and the generation of an action potential. Consequently, the propagation of nerve impulses along sensory nerve fibers is interrupted, leading to a temporary and reversible loss of sensation (anesthesia) in the area of application. This action is specific to the nerve tissue, providing superficial anesthesia to the cornea and conjunctiva without significantly affecting deeper ocular structures. The onset of anesthesia is typically rapid, occurring within 15 to 20 seconds, and the duration of action is relatively short, lasting approximately 10 to 20 minutes, making it suitable for brief ophthalmic procedures. Its chemical structure as an ester also dictates its metabolism.
Commercial Brands (Alternatives)
No other brands found for this formula.